Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 359

COVID Susceptibility Index can help to manage outbreaks

Background: At a recent UNSW virtual research seminar, Calise Liu and Alan Xian presented their research on developing a COVID-19 Susceptibility Index. This interview explores the research and its potential applications. Calise works at Finity Consulting, which specialises in actuarial and strategic analytics consulting. Alan has nearly finished his PhD at UNSW and will start a role at Macquarie University later this year. 

David: With your actuarial backgrounds, what motivated you to get involved in COVID-19 research, which to many is the domain of medical researchers?

Calise: Once you have data (and there is a lot of data available), many of the skills required to analyse that data are universal. We had read a lot of medical literature but hadn’t seen the translation of those results to the Australian population. Actuaries are particularly well-placed because we have expertise in modelling large demographic data sets. Of course, we are not medical experts and so we made sure to get specialist medical input. We held discussions with six medical experts on the design aspects of our research.

David: Why the focus on susceptibility?

Alan: There was already a lot of research modelling transmission of the virus. We noticed a research gap in terms of investigating susceptibility at a demographic level. Susceptibility, the risk of severe illness or death if an individual were to contract the virus, is important in many ways. At a government level, susceptibility tells you how bad it could be in each region if an outbreak were to occur. This then informs decisions around resource allocation and how quickly you want to be able to identify and treat known cases.

David: Explain how you have developed the Susceptibility Index.

Alan: We combined age characteristics (60-69, 70-79, and 80+) with five health aspects (known as co-morbidities): cardiovascular disease, respiratory disease, cancer, diabetes and obesity. Unfortunately, the data shows that certain groups – notably the elderly with multiple health issues – are many times more likely to have severe reactions if infected with COVID-19, compared with young healthy people.

Calise: By combining our susceptibility score with Finity’s Defin’d dataset of socio-demographic and geographic attributes, we can explore COVID-19 impacts by area, household composition, income band, industry and more. We found some evidence of vulnerable populations away from capital cities, where multiple risk factors are more concentrated. We used heatmaps to visualise the susceptibility risk (red indicates areas with, on average, highest susceptibility).

The news is both good and bad. So far, most of the cases have occurred in areas with relatively-lower susceptibility. However, this is something to consider when looking at when, where and how to relax restrictions.

David: When you combine the demographic data with age and health factors, do any socio-economic effects emerge?

Alan: Unfortunately, we find that at-risk communities commonly have low socio-economic characteristics (i.e. low income). This isn’t surprising – when we spoke to our medical experts, they were aware that health issues and co-morbidities tend to present more strongly in poorer socio-economic groups. As a result, the disadvantaged segments of Australia may require additional resources as we start relaxing isolation measures.

David: What are the implications for government policy?

Calise: We think our work can inform policy in a number of ways. Our model provides an exposure measure for the Australian population that can serve as a foundation for various extensions. Transmission information can be overlaid to assess the impact of various policies. Our analysis can also highlight areas where outbreaks of COVID-19 may be particularly devastating, guiding decisions around allocation of financial and medical resources. Conversely, the additional economic information could be incorporated to examine trade-offs between simulating economic recovery and minimising risk to public safety.

David: I know this is early days, but have you been able to share this research with authorities?

Alan: We have had some interest from the Department of Health. We are happy to work with any interested parties to see how our work could be of assistance.

David: Finally, Alan, you’ve effectively put your PhD on hold, and Calise, you’ve been supported by Finity, but most of this research is outside of work hours. Do you think that this may be a feature of your future careers, jumping into projects outside your core line of research where you see the opportunity to contribute?

Calise: I think many young people view contribution as an important part of their career. I’m fortunate to have an analytical skillset which can be applied to different problems. 

Alan: I do have to finish my PhD soon and am looking forward to that light at the end of the tunnel. Luckily, I have supportive supervisors who share my view that these contributions are worthwhile pursuits. At the start of my PhD, what I really wanted was to produce societally beneficial research and so these projects are very exciting. 

 

Individuals with co-morbidities or symptoms associated with COVID-19 should follow the government advice and take extra precautions which can be found here.

If you would like to know more about the Susceptibility Index you can read more here.

 

David Bell is Executive Director of The Conexus Institute, a not-for-profit research institution focused on improving retirement outcomes for Australians. Calise Liu is a Fellow of the Institute of Actuaries of Australia and an intern at Finity Consulting. Alan Xian is a PhD candidate at UNSW.

 


 

Leave a Comment:

     

RELATED ARTICLES

Baby bust: will infertility shape Australia's future?

Four ethical challenges in exiting Covid-19 rules

The demographics of a growing (and ageing) Australia

banner

Most viewed in recent weeks

Unexpected results in our retirement income survey

Who knew? With some surprise results, the Government is on unexpected firm ground in asking people to draw on all their assets in retirement, although the comments show what feisty and informed readers we have.

10 reasons wealthy homeowners shouldn't receive welfare

The RBA Governor says rising house prices are due to "the design of our taxation and social security systems". The OECD says "the prolonged boom in house prices has inflated the wealth of many pensioners without impacting their pension eligibility." What's your view?

Three all-time best tables for every adviser and investor

It's a remarkable statistic. In any year since 1875, if you had invested in the Australian stock index, turned away and come back eight years later, your average return would be 120% with no negative periods.

The looming excess of housing and why prices will fall

Never stand between Australian households and an uncapped government programme with $3 billion in ‘free money’ to build or renovate their homes. But excess supply is coming with an absence of net migration.

Five stocks that have worked well in our portfolios

Picking macro trends is difficult. What may seem logical and compelling one minute may completely change a few months later. There are better rewards from focussing on identifying the best companies at good prices.

Six COVID opportunist stocks prospering in adversity

Some high-quality companies have emerged even stronger since the onset of COVID and are well placed for outperformance. We call these the ‘COVID Opportunists’ as they are now dominating their specific sectors.

Latest Updates

Retirement

10 reasons wealthy homeowners shouldn't receive welfare

The RBA Governor says rising house prices are due to "the design of our taxation and social security systems". The OECD says "the prolonged boom in house prices has inflated the wealth of many pensioners without impacting their pension eligibility." What's your view?

Interviews

Sean Fenton on marching to your own investment tune

Is it more difficult to find stocks to short in a rising market? What impact has central bank dominance had over stock selection? How do you combine income and growth in a portfolio? Where are the opportunities?

Compliance

D’oh! DDO rules turn some funds into a punching bag

The Design and Distribution Obligations (DDO) come into effect in two weeks. They will change the way banks promote products, force some small funds to close to new members and push issues into the listed space.

Shares

Dividends, disruption and star performers in FY21 wrap

Company results in FY21 were generally good with some standout results from those thriving in tough conditions. We highlight the companies that delivered some of the best results and our future  expectations.

Fixed interest

Coles no longer happy with the status quo

It used to be Down, Down for prices but the new status quo is Down Down for emissions. Until now, the realm of ESG has been mainly fund managers as 'responsible investors', but companies are now pushing credentials.

Investment strategies

Seven factors driving growth in Managed Accounts

As Managed Accounts surge through $100 billion for the first time, the line between retail, wholesale and institutional capabilities and portfolios continues to blur. Lower costs help with best interest duties.

Retirement

Reader Survey: home values in age pension asset test

Read our article on the family home in the age pension test, with the RBA Governor putting the onus on social security to address house prices and the OECD calling out wealthy pensioners. What is your view?

Sponsors

Alliances

© 2021 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. Any general advice or ‘regulated financial advice’ under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.

Website Development by Master Publisher.